Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 752 filings
- On EDGAR
- CIK 1404644
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 53
News 8 of 153
Prospectuses and Registrations 8 of 46
- 424B5 Prospectus supplement for an offering Jul 2, 2026
- 424B5 Prospectus supplement for an offering Jun 30, 2026
- S-8 Registration statement for an employee plan Mar 24, 2026
- 424B5 Prospectus supplement for an offering Aug 11, 2025
- 424B3 Prospectus supplement for an offering Apr 1, 2025
- S-3 Shelf registration statement Mar 24, 2025
- POS AM Post-effective amendment to a registration Mar 24, 2025
- S-8 Registration statement for an employee plan Mar 24, 2025
Proxies 8 of 27
- DEFA14A Extra proxy material Apr 16, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 27, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2023
Ownership 8 of 408
- SCHEDULE 13G Large holder reported a passive stake Oct 7, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 6, 2026
- 4 Insider reported a trade Oct 2, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Jul 7, 2026
- 4 Insider reported a trade Jul 2, 2026
Other 8 of 65
- ARS Annual report sent to shareholders Apr 16, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- EFFECT Notice that a registration became effective Apr 4, 2025
- CORRESP Reply to SEC staff Apr 2, 2025
- UPLOAD Comment letter from SEC staff Mar 31, 2025
- EFFECT Notice that a registration became effective Mar 28, 2025
- EFFECT Notice that a registration became effective Dec 16, 2024
- CORRESP Reply to SEC staff Dec 12, 2024
Everything here comes from Neurogene Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.